DANIELA SALAZAR: Open Payments
NPI 1487286803 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$874 in 10 payments from 7 companies in 2025. Trend: 2023 $136 · 2024 $133 · 2025 $874
Food & beverage: $873Travel & lodging: $1
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $243 |
| Solventum Corporation | 1 | $150 |
| AstraZeneca Pharmaceuticals LP | 2 | $137 |
| Gilead Sciences, Inc. | 1 | $122 |
| PFIZER INC. | 1 | $114 |
| ABBVIE INC. | 1 | $59 |
| Intra-Sana Laboratories | 1 | $50 |
Products named: ZEPBOUND, PREVENA, Yeztugo, AIRSUPRA, NURTEC ODT, MAVYRET, RELTONE 200 MG, WAINUA.
Industry payments across CA — which companies pay providers there.
